Human–machine harmonization to upgrade biopharma production
Biopharma companies are under pressure to boost their output, but complex, fragile production processes are holding them back. AI and analytics could offer a cure for the industry’s ills.
Biopharma companies are under pressure to boost their output, but complex, fragile production processes are holding them back. AI and analytics could offer a cure for the industry’s ills.
